© 1995 British Society for Rheumatology
research-article |
RELATIONSHIP BETWEEN SERUM CARTILAGE OLIGOMERIC MATRIX PROTEIN LEVELS AND DISEASE PROGRESSION IN OSTEOARTHRITIS OF THE KNEE JOINT
,
*University of Bristol Rheumatology Unit, Bristol Royal Infirmary Bristol
Department of Rheumatology Bristol
Department of Medical and Physiological Chemistry, Lund University Sweden
Department of Microbiology and Pathology, University of Bristol Bristol
Correspondence to:
Correspondence to: M. Sharif, Rheumatology Unit, University Department of Medicine, Bristol Royal Infirmary, Marlborough Street, Bristol BS2 8HW.
The value of serum cartilage oligomeric matrix protein (COMP) as a marker of disease progression was investigated in 81 hospital out-patients with clinical knee osteoarthritis (OA). Progressing patients were defined by a decrease of 
2 mm in joint space on X-ray or requiring knee surgery during the 5 yr of follow-up. Of the 57 patients for whom full data were available, 20 progressed and 37 did not progress. Serum COMP levels increased during the first year in those who progressed (mean 6.42 µg/ml) (S.D. 6.64) compared to those who did not progress [mean 0.07 µg/ml (S.D. 4.99); P < 0.001]. Changes in COMP during the first year were related to baseline COMP (r = –0.672, P<0.001) and weight-to-height ratio (r = 0.272, P = 0.47). After allowing for these variables, serum COMP increased during the first year in progressive patients by 5.04 µg/ml [95% confidence interval (CI): (2.61, 7.46)] more than in non-progressive patients. Discriminant analysis gave a sensitivity of 70% and specificity of 78% at a cut-off value of 3.17 µg/ml. Baseline serum COMP levels did not differ between the groups but were related to late phase scintigraphy scan abnormalities. These observations suggest that the changes in serum COMP may have prognostic significance and are consistent with a model of OA in which early signs of episodic clinical progression can be found in the cartilage as well as in subchondral bone.
KEY WORDS: Cartilage oligomeric matrix protein, Osteoarthritis, Disease progression
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Sharif, J. Kirwan, N. Charni, L. J. Sandell, C. Whittles, and P. Garnero A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression Rheumatology, June 1, 2007; 46(6): 938 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. V. von Steyern, I. Kristiansson, K. Jonsson, P. Mannfolk, D. Heinegard, and A. Rydholm Giant-cell tumour of the knee: THE CONDITION OF THE CARTILAGE AFTER TREATMENT BY CURETTAGE AND CEMENTING J Bone Joint Surg Br, March 1, 2007; 89-B(3): 361 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pothacharoen, S. Siriaunkgul, S. Ong-Chai, J. Supabandhu, P. Kumja, C. Wanaphirak, K. Sugahara, T. Hardingham, and P. Kongtawelert Raised Serum Chondroitin Sulfate Epitope Level in Ovarian Epithelial Cancer J. Biochem., October 1, 2006; 140(4): 517 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O Bruyere, J Collette, M Kothari, S Zaim, D White, H Genant, C Peterfy, N Burlet, D Ethgen, T Montague, et al. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study Ann Rheum Dis, August 1, 2006; 65(8): 1050 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Mazieres, P Garnero, A Gueguen, M Abbal, L Berdah, M Lequesne, M Nguyen, J-P Salles, E Vignon, and M Dougados Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort Ann Rheum Dis, March 1, 2006; 65(3): 354 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Senolt, M Braun, M Olejarova, S Forejtova, J Gatterova, and K Pavelka Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein Ann Rheum Dis, June 1, 2005; 64(6): 886 - 890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Smith, M. Wetherall, T. Darby, A. Esterman, J. Slavotinek, P. Roberts-Thomson, M. Coleman, and M. J. Ahern A randomized placebo-controlled trial of arthroscopic lavage versus lavage plus intra-articular corticosteroids in the management of symptomatic osteoarthritis of the knee Rheumatology, December 1, 2003; 42(12): 1477 - 1485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S A Mazzuca, K D Brandt, N C German, K A Buckwalter, K A Lane, and B P Katz Development of radiographic changes of osteoarthritis in the """Chingford knee""" reflects progression of disease or non-standardised positioning of the joint rather than incident disease Ann Rheum Dis, November 1, 2003; 62(11): 1061 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Sugiyama, M Itokazu, Y Suzuki, and K Shimizu Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis Ann Rheum Dis, January 1, 2003; 62(1): 27 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hogervorst, T. H. Pels Rijcken, D. Rucker, C. P. van der Hart, and W. K. Taconis Changes in Bone Scans after Anterior Cruciate Ligament Reconstruction: A Prospective Study Am. J. Sports Med., November 1, 2002; 30(6): 823 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E Murphy, O FitzGerald, T Saxne, and B Bresnihan Increased serum cartilage oligomeric matrix protein levels and decreased patellar bone mineral density in patients with chondromalacia patellae Ann Rheum Dis, November 1, 2002; 61(11): 981 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Miyazaki, M Wada, H Kawahara, M Sato, H Baba, and S Shimada Dynamic load at baseline can predict radiographic disease progression in medial compartment knee osteoarthritis Ann Rheum Dis, July 1, 2002; 61(7): 617 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Swan, H Amer, and P Dieppe The value of synovial fluid assays in the diagnosis of joint disease: a literature survey Ann Rheum Dis, June 1, 2002; 61(6): 493 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Garnero, M Piperno, E Gineyts, S Christgau, P D Delmas, and E Vignon Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage Ann Rheum Dis, June 1, 2001; 60(6): 619 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Delot, S. G. Brodie, L. M. King, W. R. Wilcox, and D. H. Cohn Physiological and Pathological Secretion of Cartilage Oligomeric Matrix Protein by Cells in Culture J. Biol. Chem., October 9, 1998; 273(41): 26692 - 26697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Conrozier, T. Saxne, C. S. S. Fan, P. Mathieu, A.-M. Tron, D. Heinegård, and E. Vignon Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: A one year prospective study Ann Rheum Dis, September 1, 1998; 57(9): 527 - 532. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. A. BUCKWALTER and H. J. MANKIN Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Articular Cartilage. Part I: Tissue Design and Chondrocyte-Matrix Interactions*{{dagger}} J. Bone Joint Surg. Am., April 1, 1997; 79(4): 600 - 11. [Full Text]
|
|